Sarah Pringle

Sarah Pringle is a senior reporter focused on M&A, private equity and auctions in the healthcare industry. Prior to joining The Deal, Pringle reported on U.S. and Canadian equity markets at Bloomberg News in New York and MarketWatch in San Francisco.

Recent Articles By The Author

Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different

Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different

CEO Joe Papa tried to distance the company from its past troubles at the annual J.P. Morgan Healthcare Conference.

Allergan Hints It Is Ready to Make a Splash for More Near-term Growth

Allergan Hints It Is Ready to Make a Splash for More Near-term Growth

CEO Brent Saunders plans to reward shareholders after striking a slew of R&D acquisitions in the latter half of 2016.

Trump Tax Policies Could Make J&J a Bigger Threat in 2017

Trump Tax Policies Could Make J&J a Bigger Threat in 2017

While there remains many unknowns about the specifics of possible legislation, CEO Alex Gorsky suggested that tax reform and repatriation could be a major game changer for J&J.

Here Are 6 Things to Watch Out for at J.P. Morgan's Healthcare Conference Next Week

Here Are 6 Things to Watch Out for at J.P. Morgan's Healthcare Conference Next Week

Next week the J.P. Morgan Healthcare Conference becomes the hottest spot in biotech and pharma.